查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1587707

2030 年眼科器材市場預測：按產品、應用、最終用戶和地區分類的全球分析

Ophthalmic Devices Market Forecasts to 2030 - Global Analysis By Product, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2024 年全球眼科器材市場規模為 74 億美元，預計到 2030 年將達到 103 億美元，預測期內複合年成長率為 5.7%。

稱為眼科設備的專用儀器和設備用於診斷、追蹤和治療各種眼科疾病。此類產品包括隱形眼鏡、超音波乳化器、人工水晶體、裂隙燈和光同調斷層掃瞄。這些儀器對於眼部保健、手術和視力改善至關重要。眼科醫療設備隨著技術進步而不斷發展，改善了世界各地眼科護理程序的患者治療結果、準確性和效率。

根據世界衛生組織 (WHO) 統計，至少有 22 億人患有近視或遠視。其中至少有十億人患有可預防或未經治療的視力喪失。 90% 視力障礙和失明未解決的人生活在低收入和中等收入國家 (LMIC)。

視力障礙盛行率增加

青光眼、白內障和糖尿病視網膜病變等視力障礙發病率的增加是眼科醫療設備市場的關鍵促進因素。隨著世界人口老化，與老齡化相關的眼科疾病率增加，對診斷和治療設備的需求增加。此外，螢幕時間增加和營養不良等生活方式因素也會導致屈光不正和其他眼科疾病的增加。這一趨勢需要先進的眼科設備來進行早期檢測、準確診斷和有效治療，從而推動市場成長。

高成本

飛秒雷射和人工智慧診斷工具等最尖端科技價格昂貴，對於發展中地區和小型診所的醫療保健提供者來說是遙不可及的。此外，使用這些設備進行治療的高昂費用可能會讓患者望而卻步，尤其是在保險覆蓋範圍和報銷選擇有限的地區。這種成本障礙可能會減緩新技術的採用並限制市場擴張。

門診手術中心增加

與傳統醫院相比，門診手術中心為許多眼科手術提供了更具成本效益和效率的選擇。這一趨勢推動了對門診病人使用的緊湊、攜帶式和易於使用的眼科設備的需求。 ASC 的興起也促使製造商開發創新設備，以提高這些專業設施的手術效率和病患治療效果。隨著越來越多的患者選擇方便且節省成本的 ASC，適應這種環境的眼科設備市場預計將顯著成長。

與眼科手術相關的風險

儘管技術不斷進步，白內障手術、 LASIK和視網膜手術等手術仍存在潛在的併發症，如感染疾病、視力喪失和需要額外手術。這些風險可能導致患者猶豫並加強監管機構的監督，從而減緩新手術技術和設備的採用。此外，與眼科醫療設備相關的引人注目的事件或召回可能會削弱消費者的信心並影響市場成長。

COVID-19 的影響：

由於選擇性手術延遲和患者就診次數減少，COVID-19 大流行最初擾亂了眼科器械市場。然而，大流行加速了遠端醫療和遠距離診斷工具在眼科領域的採用。疫情凸顯了對創新非接觸式測試設備的需求，刺激了人工智慧診斷解決方案的開拓，並可能重塑市場格局並推動數位眼技術的長期成長。

醫院和診所預計在預測期內將是最大的

預計醫院和診所部門將在預測期內佔據市場佔有率。這一優勢歸功於這些環境中提供的全面眼科護理服務，從常規檢查到複雜的手術程序。醫院和診所通常有財力投資先進的眼科設備和技術，因此他們在採用新設備方面處於領先地位。此外，整合醫院和專業眼科診所眼科護理服務的趨勢進一步鞏固了該細分市場的市場主導地位。

屈光不良領域預計在預測期內複合年成長率最高

屈光不良領域預計在預測期內將出現良好的成長。這種快速成長是由於屈光的盛行率不斷增加，特別是全球範圍內的近視、遠視和散光。螢幕時間增加、都市化和生活型態改變等因素導致這些疾病的發生率上升。該領域的成長將進一步受到診斷和治療設備技術進步的推動，例如先進的波前像差儀和用於屈光矯正手術的飛秒雷射。

佔比最大的地區：

預計北美地區在預測期內將佔據最大的市場佔有率。這一優勢得益於該地區先進的醫療基礎設施、高昂的醫療成本以及較早採用創新醫療技術。北美主要市場參與者和研究機構的存在促進了眼科醫療設備的持續創新和產品開發。此外，該地區人口老化和眼科疾病率高，加上優惠的報銷政策和眼部健康意識的提高，導致該地區對眼科醫療設備的強勁需求。

複合年成長率最高的地區：

預計亞太地區在預測期內的複合年成長率最高。這種快速成長歸因於該地區人口眾多且不斷成長、眼科疾病率不斷上升以及醫療基礎設施的改善。在中國和印度等國家，可支配收入的增加和眼睛健康意識的提高正在推動對先進眼科護理的需求。該地區的眼保健醫療旅遊也在迅速成長，特別是在以具有競爭力的價格提供高品質護理的國家。此外，政府改善醫療保健服務和擴大私人眼科護理設施的舉措正在為市場成長創造有利條件。

免費客製化服務：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭標基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 研究資訊來源
    • 主要研究資訊來源
    • 二次研究資訊來源
    • 先決條件

第3章市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • COVID-19 的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球眼科器材市場：依產品

  • 診斷和監測設備
    • 光學同調斷層掃描裝置
    • 眼底攝影機
    • 視野/視野分析儀
    • 自動驗光儀和角膜曲率計
    • 眼壓計
    • 裂隙燈
    • 綜合屈光檢查
    • 波前像差儀
    • 光學生物辨識系統
    • 眼底鏡
    • 焦度計
    • 角膜地圖儀系統
    • 鏡面顯微鏡
    • 檢影鏡
  • 手術設備
    • 白內障手術裝置
    • 青光眼手術設備
    • 屈光矯正手術裝置
    • 玻璃體視網膜手術裝置
  • 視力保健產品
    • 隱形眼鏡
    • 眼鏡鏡片
  • 眼科超音波影像系統
    • 眼科A掃描超音波
    • 眼科B超音波
    • 超音波超音波生物顯微鏡
    • 眼科角膜測厚器
  • 其他產品

第6章全球眼科器材市場：依應用分類

  • 白內障
  • 青光眼
  • 屈光不正
  • 糖尿病視網膜病變
  • 老齡化黃斑部病變（AMD）
  • 乾眼症
  • 其他用途

第7章全球眼科器材市場：依最終使用者分類

  • 醫院和診所
  • 日間手術中心 (ASC)
  • 眼科治療
  • 研究所

第8章全球眼科器材市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第9章 主要進展

  • 合約、夥伴關係、合作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第 10 章 公司概況

  • Alcon Inc.
  • Johnson & Johnson Vision Care
  • Bausch Health Companies Inc
  • Carl Zeiss Meditec AG
  • EssilorLuxottica SA
  • Hoya Corporation
  • Nidek Co. Ltd
  • Topcon Corporation
  • Ziemer Ophthalmic Systems AG
  • Haag-Streit Group
  • Volk Optical Inc
  • Optovue Inc
  • Glaukos Corporation
  • STAAR Surgical Co
  • Canon Inc
  • Novartis AG
  • Cooper Companies, Inc
  • Iridex Corporation
Product Code: SMRC27700

According to Stratistics MRC, the Global Ophthalmic Devices Market is accounted for $7.4 billion in 2024 and is expected to reach $10.3 billion by 2030, growing at a CAGR of 5.7% during the forecast period. Specialized instruments and tools known as ophthalmic devices are used to diagnose, track, and treat a variety of eye disorders. Products in this category include contact lenses, phacoemulsification equipment, intraocular lenses, slit lamps, and optical coherence tomography machines. These tools are essential for managing eye health, performing surgeries, and improving vision. Ophthalmic devices continue to evolve as a result of technological advancements, improving patient outcomes, accuracy, and efficiency in eye care procedures all over the world.

According to the World Health Organization (WHO), at least 2.2 billion people have a near or distance vision impairment. In at least 1 billion of these cases, vision impairment could have been prevented or is yet to be addressed. And of those with unaddressed vision impairment or blindness, 90% live in low- and middle-income countries (LMICs).

Market Dynamics:

Driver:

Increasing prevalence of optical disorders

The rising incidence of optical disorders such as glaucoma, cataracts, and diabetic retinopathy is a significant driver for the ophthalmic devices market. As the global population ages, the prevalence of age-related eye conditions increases, creating a growing demand for diagnostic and treatment devices. Additionally, lifestyle factors like increased screen time and poor nutrition contribute to the rise in refractive errors and other eye problems. This trend necessitates advanced ophthalmic devices for early detection, accurate diagnosis, and effective treatment, thereby fueling market growth.

Restraint:

High costs

Cutting-edge technologies like femtosecond lasers and AI-powered diagnostic tools come with substantial price tags, making them less accessible to healthcare providers in developing regions or smaller clinics. Moreover, the high cost of treatments using these devices can be prohibitive for patients, especially in areas with limited insurance coverage or reimbursement options. This cost barrier can slow down the adoption of new technologies and limit market expansion.

Opportunity:

Increase in ambulatory surgery centers

ASCs offer a more cost-effective and efficient alternative to traditional hospital settings for many ophthalmic procedures. This trend is driving demand for compact, portable, and user-friendly ophthalmic devices tailored to outpatient settings. The rise of ASCs also encourages manufacturers to develop innovative devices that enhance procedural efficiency and patient outcomes in these specialized facilities. As more patients opt for the convenience and reduced costs of ASCs, the market for ophthalmic devices adapted to these settings is expected to expand considerably.

Threat:

Risk associated with ophthalmic surgeries

Despite technological advancements, procedures like cataract surgery, LASIK, and retinal surgeries carry potential complications such as infection, vision loss, or the need for additional surgeries. These risks can lead to patient hesitation and increased scrutiny from regulatory bodies, potentially slowing down the adoption of new surgical techniques and devices. Additionally, any high-profile incidents or recalls related to ophthalmic devices can damage consumer confidence and impact market growth.

Covid-19 Impact:

The COVID-19 pandemic initially disrupted the ophthalmic devices market due to postponed elective surgeries and reduced patient visits. However, it also accelerated the adoption of telemedicine and remote diagnostic tools in ophthalmology. The pandemic highlighted the need for innovative, contactless examination devices and spurred the development of AI-powered diagnostic solutions, reshaping the market landscape and potentially driving long-term growth in digital ophthalmic technologies.

The hospitals and clinics segment is expected to be the largest during the forecast period

Over the forecasted timeframe, the hospitals and clinics segment is anticipated to dominate the market share. This dominance can be attributed to the comprehensive range of eye care services offered in these settings, from routine check-ups to complex surgical procedures. Hospitals and clinics typically have the financial resources to invest in advanced ophthalmic equipment and technologies, making them primary adopters of new devices. Additionally, the trend towards integrated eye care services in hospitals and specialized eye clinics further solidifies this segment's leading position in the market.

The refractive disorders segment is expected to have the highest CAGR during the forecast period

The refractive disorders segment is expected to register lucrative growth during the estimation period. This rapid growth can be attributed to the increasing prevalence of refractive errors worldwide, particularly myopia, hyperopia, and astigmatism. Factors such as increased screen time, urbanization, and changing lifestyles contribute to the rising incidence of these disorders. The segment's growth is further fueled by technological advancements in diagnostic and treatment devices, including advanced wavefront aberrometers and femtosecond lasers for refractive surgeries.

Region with largest share:

Over the forecast period, the North America region is anticipated to hold the largest market share. This dominance can be attributed to the region's advanced healthcare infrastructure, high healthcare expenditure, and early adoption of innovative medical technologies. The presence of major market players and research institutions in North America drives continuous innovation and product development in ophthalmic devices. Additionally, the region's aging population and high prevalence of eye disorders, coupled with favorable reimbursement policies and increased awareness of eye health, contribute to the strong demand for ophthalmic devices in the region.

Region with highest CAGR:

Over the forecasted timeframe, the Asia Pacific region is anticipated to exhibit the highest CAGR. This rapid growth can be attributed to the region's large and growing population, increasing prevalence of eye disorders, and improving healthcare infrastructure. Rising disposable incomes and growing awareness of eye health in countries like China and India are driving demand for advanced ophthalmic treatments. The region is also witnessing a surge in medical tourism for eye care, particularly in countries offering high-quality treatments at competitive prices. Moreover, government initiatives to improve healthcare access and the expansion of private eye care facilities are creating favorable conditions for market growth.

Key players in the market

Some of the key players in Ophthalmic Devices Market include Alcon Inc., Johnson & Johnson Vision Care, Bausch Health Companies Inc., Carl Zeiss Meditec AG, EssilorLuxottica SA, Hoya Corporation, Nidek Co. Ltd., Topcon Corporation, Ziemer Ophthalmic Systems AG, Haag-Streit Group, Volk Optical Inc., Optovue Inc., Glaukos Corporation, STAAR Surgical Co., Canon Inc., Novartis AG, Cooper Companies, Inc., and Iridex Corporation.

Key Developments:

In September 2024, Johnson & Johnson, a global leader in eye health, announced the expansion of its latest advancement in presbyopia-correcting intraocular lenses (PC-IOL), TECNIS Odyssey, in the U.S. The new full visual range IOL offers patients unmatched continuous full range of vision, allowing them to see clearly from far to near and in between, minimizing their need for glasses. The TECNIS Odyssey IOL is built on the TECNIS platform, providing twice the contrast in low lighting compared to PanOptix.

In July 2024, Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced the closing of its deal to acquire BELKIN Vision with a total upfront consideration of $81M, including a cash payment of approximately $65M.

In April 2024, Carl Zeiss Meditec AG announced that, after securing all required regulatory approvals, it has completed the acquisition of 100% of D.O.R.C. (Dutch Ophthalmic Research Center) from the investment firm Eurazeo SE, Paris, France. The acquisition enhances and complements ZEISS Medical Technology's broad ophthalmic portfolio and range of digitally connected workflow solutions for addressing a wide variety of eye conditions, spanning retina and cornea disorders, cataract, glaucoma, and refractive errors.

Products Covered:

  • Diagnostic and Monitoring Devices
  • Surgical Devices
  • Vision Care Products
  • Ophthalmic Ultrasound Imaging Systems
  • Other Products

Applications Covered:

  • Cataract
  • Glaucoma
  • Refractive Disorders
  • Diabetic Retinopathy
  • Age-Related Macular Degeneration (AMD)
  • Dry Eye
  • Other Applications

End Users Covered:

  • Hospitals and Clinics
  • Ambulatory Surgery Centers (ASCs)
  • Ophthalmic Practices
  • Research Institutes

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Ophthalmic Devices Market, By Product

  • 5.1 Introduction
  • 5.2 Diagnostic and Monitoring Devices
    • 5.2.1 Optical Coherence Tomography Scanners
    • 5.2.2 Fundus Cameras
    • 5.2.3 Perimeters/Visual Field Analysers
    • 5.2.4 Autorefractors and Keratometers
    • 5.2.5 Tonometers
    • 5.2.6 Slit Lamps
    • 5.2.7 Phoropters
    • 5.2.8 Wavefront Aberrometers
    • 5.2.9 Optical Biometry Systems
    • 5.2.10 Ophthalmoscopes
    • 5.2.11 Lensmeters
    • 5.2.12 Corneal Topography Systems
    • 5.2.13 Specular Microscopes
    • 5.2.14 Retinoscopes
  • 5.3 Surgical Devices
    • 5.3.1 Cataract Surgery Devices
    • 5.3.2 Glaucoma Surgery Devices
    • 5.3.3 Refractive Surgery Devices
    • 5.3.4 Vitreoretinal Surgery Devices
  • 5.4 Vision Care Products
    • 5.4.1 Contact Lenses
    • 5.4.2 Spectacle Lenses
  • 5.5 Ophthalmic Ultrasound Imaging Systems
    • 5.5.1 Ophthalmic A-Scan Ultrasound
    • 5.5.2 Ophthalmic B-Scan Ultrasound
    • 5.5.3 Ophthalmic Ultrasound Biomicroscopes
    • 5.5.4 Ophthalmic Pachymeters
  • 5.6 Other Products

6 Global Ophthalmic Devices Market, By Application

  • 6.1 Introduction
  • 6.2 Cataract
  • 6.3 Glaucoma
  • 6.4 Refractive Disorders
  • 6.5 Diabetic Retinopathy
  • 6.6 Age-Related Macular Degeneration (AMD)
  • 6.7 Dry Eye
  • 6.8 Other Applications

7 Global Ophthalmic Devices Market, By End User

  • 7.1 Introduction
  • 7.2 Hospitals and Clinics
  • 7.3 Ambulatory Surgery Centers (ASCs)
  • 7.4 Ophthalmic Practices
  • 7.5 Research Institutes

8 Global Ophthalmic Devices Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Alcon Inc.
  • 10.2 Johnson & Johnson Vision Care
  • 10.3 Bausch Health Companies Inc
  • 10.4 Carl Zeiss Meditec AG
  • 10.5 EssilorLuxottica SA
  • 10.6 Hoya Corporation
  • 10.7 Nidek Co. Ltd
  • 10.8 Topcon Corporation
  • 10.9 Ziemer Ophthalmic Systems AG
  • 10.10 Haag-Streit Group
  • 10.11 Volk Optical Inc
  • 10.12 Optovue Inc
  • 10.13 Glaukos Corporation
  • 10.14 STAAR Surgical Co
  • 10.15 Canon Inc
  • 10.16 Novartis AG
  • 10.17 Cooper Companies, Inc
  • 10.18 Iridex Corporation

List of Tables

  • Table 1 Global Ophthalmic Devices Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Ophthalmic Devices Market Outlook, By Product (2022-2030) ($MN)
  • Table 3 Global Ophthalmic Devices Market Outlook, By Diagnostic and Monitoring Devices (2022-2030) ($MN)
  • Table 4 Global Ophthalmic Devices Market Outlook, By Optical Coherence Tomography Scanners (2022-2030) ($MN)
  • Table 5 Global Ophthalmic Devices Market Outlook, By Fundus Cameras (2022-2030) ($MN)
  • Table 6 Global Ophthalmic Devices Market Outlook, By Perimeters/Visual Field Analysers (2022-2030) ($MN)
  • Table 7 Global Ophthalmic Devices Market Outlook, By Autorefractors and Keratometers (2022-2030) ($MN)
  • Table 8 Global Ophthalmic Devices Market Outlook, By Tonometers (2022-2030) ($MN)
  • Table 9 Global Ophthalmic Devices Market Outlook, By Slit Lamps (2022-2030) ($MN)
  • Table 10 Global Ophthalmic Devices Market Outlook, By Phoropters (2022-2030) ($MN)
  • Table 11 Global Ophthalmic Devices Market Outlook, By Wavefront Aberrometers (2022-2030) ($MN)
  • Table 12 Global Ophthalmic Devices Market Outlook, By Optical Biometry Systems (2022-2030) ($MN)
  • Table 13 Global Ophthalmic Devices Market Outlook, By Ophthalmoscopes (2022-2030) ($MN)
  • Table 14 Global Ophthalmic Devices Market Outlook, By Lensmeters (2022-2030) ($MN)
  • Table 15 Global Ophthalmic Devices Market Outlook, By Corneal Topography Systems (2022-2030) ($MN)
  • Table 16 Global Ophthalmic Devices Market Outlook, By Specular Microscopes (2022-2030) ($MN)
  • Table 17 Global Ophthalmic Devices Market Outlook, By Retinoscopes (2022-2030) ($MN)
  • Table 18 Global Ophthalmic Devices Market Outlook, By Surgical Devices (2022-2030) ($MN)
  • Table 19 Global Ophthalmic Devices Market Outlook, By Cataract Surgery Devices (2022-2030) ($MN)
  • Table 20 Global Ophthalmic Devices Market Outlook, By Glaucoma Surgery Devices (2022-2030) ($MN)
  • Table 21 Global Ophthalmic Devices Market Outlook, By Refractive Surgery Devices (2022-2030) ($MN)
  • Table 22 Global Ophthalmic Devices Market Outlook, By Vitreoretinal Surgery Devices (2022-2030) ($MN)
  • Table 23 Global Ophthalmic Devices Market Outlook, By Vision Care Products (2022-2030) ($MN)
  • Table 24 Global Ophthalmic Devices Market Outlook, By Contact Lenses (2022-2030) ($MN)
  • Table 25 Global Ophthalmic Devices Market Outlook, By Spectacle Lenses (2022-2030) ($MN)
  • Table 26 Global Ophthalmic Devices Market Outlook, By Ophthalmic Ultrasound Imaging Systems (2022-2030) ($MN)
  • Table 27 Global Ophthalmic Devices Market Outlook, By Ophthalmic A-Scan Ultrasound (2022-2030) ($MN)
  • Table 28 Global Ophthalmic Devices Market Outlook, By Ophthalmic B-Scan Ultrasound (2022-2030) ($MN)
  • Table 29 Global Ophthalmic Devices Market Outlook, By Ophthalmic Ultrasound Biomicroscopes (2022-2030) ($MN)
  • Table 30 Global Ophthalmic Devices Market Outlook, By Ophthalmic Pachymeters (2022-2030) ($MN)
  • Table 31 Global Ophthalmic Devices Market Outlook, By Other Products (2022-2030) ($MN)
  • Table 32 Global Ophthalmic Devices Market Outlook, By Application (2022-2030) ($MN)
  • Table 33 Global Ophthalmic Devices Market Outlook, By Cataract (2022-2030) ($MN)
  • Table 34 Global Ophthalmic Devices Market Outlook, By Glaucoma (2022-2030) ($MN)
  • Table 35 Global Ophthalmic Devices Market Outlook, By Refractive Disorders (2022-2030) ($MN)
  • Table 36 Global Ophthalmic Devices Market Outlook, By Diabetic Retinopathy (2022-2030) ($MN)
  • Table 37 Global Ophthalmic Devices Market Outlook, By Age-Related Macular Degeneration (AMD) (2022-2030) ($MN)
  • Table 38 Global Ophthalmic Devices Market Outlook, By Dry Eye (2022-2030) ($MN)
  • Table 39 Global Ophthalmic Devices Market Outlook, By Other Applications (2022-2030) ($MN)
  • Table 40 Global Ophthalmic Devices Market Outlook, By End User (2022-2030) ($MN)
  • Table 41 Global Ophthalmic Devices Market Outlook, By Hospitals and Clinics (2022-2030) ($MN)
  • Table 42 Global Ophthalmic Devices Market Outlook, By Ambulatory Surgery Centers (ASCs) (2022-2030) ($MN)
  • Table 43 Global Ophthalmic Devices Market Outlook, By Ophthalmic Practices (2022-2030) ($MN)
  • Table 44 Global Ophthalmic Devices Market Outlook, By Research Institutes (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.